Vardenafil Research Compound Overview
Filitra 10 mg is a vardenafil-based research pharmaceutical manufactured by Fortune Health Care, specifically formulated for laboratory investigation of phosphodiesterase type 5 (PDE5) inhibitor mechanisms. This compound represents a standardised preparation enabling researchers to examine the molecular interactions and enzymatic pathways associated with PDE5 inhibition in controlled laboratory environments. Research teams investigating cardiovascular biochemistry, nitric oxide signalling pathways, and cyclic nucleotide metabolism utilise vardenafil compounds as reference standards in their analytical protocols. The 10 mg formulation provides researchers with consistent dosing parameters for comparative studies examining PDE5 selectivity profiles across different experimental conditions.
Laboratory Research Applications
Research laboratories examine Filitra 10 mg in studies investigating PDE5 enzyme kinetics, nitric oxide-cyclic guanosine monophosphate (NO-cGMP) signalling cascades, and vascular smooth muscle biochemistry. Academic institutions studying erectile dysfunction pathophysiology incorporate vardenafil compounds into their research protocols to understand the molecular mechanisms underlying vascular function regulation. Pharmaceutical research teams evaluate this compound’s selectivity profile against other phosphodiesterase enzymes to assess specificity in biochemical assays. Cardiovascular research programmes at Stroid UK Shop utilise standardised vardenafil preparations for investigating endothelial function and smooth muscle relaxation mechanisms. Researchers examining vardenafil compounds often compare results with other research areas including selective androgen receptor modulators and bioactive peptides in comprehensive endocrine studies.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Vardenafil HCl |
| Strength | 10 mg per tablet |
| Manufacturer | Fortune Health Care |
| Form | Oral tablet |
| Storage Temperature | Room temperature (15-25°C) |
| Molecular Formula | C₂₃H₃₂N₆O₄S•HCl |
| Research Applications | PDE5 inhibition studies |
| Shelf Life | Verify with supplier documentation |
Research Compliance Statement
Filitra 10 mg Fortune Health Care is manufactured exclusively for in-vitro laboratory research purposes and is not approved for human consumption, therapeutic use, or clinical applications. This research compound must be handled by qualified laboratory personnel in appropriate research facilities following institutional safety protocols and regulatory guidelines. Researchers must maintain proper documentation regarding compound procurement, storage conditions, and experimental applications in accordance with laboratory research standards. All investigations utilising this vardenafil preparation should be conducted within approved research frameworks and reported through appropriate academic or institutional channels.
